p38-MAPK is prerequisite for the synthesis of SARS-CoV-2 protein
P. Mittal, N. Khandelwal, Y. Chander, A. Verma, R. Kumar, C. Putatunda, S. Barua, B. R. Gulati, N. Kumar
Abstract
The inhibition of p38 mitogen-activated protein kinase (p38-MAPK) by small molecule chemical inhibitors was previously shown to impair severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) replication, however, mechanisms underlying antiviral activity remains unexplored. In this study, reduced growth of SARS-CoV-2 in p38- knockout Vero cells, together with enhanced viral yield in cells transfected with construct expressing p38, suggested that p38-MAPK is essential for the propagation of SARS-CoV-2. The SARS-CoV-2 was also shown to induce phosphorylation (activation) of p38, at time when transcription/translational activities are considered to be at the peak levels. Further, we demonstrated that p38 supports viral RNA/protein synthesis without affecting viral attachment, entry, and budding in the target cells. In addition, we demonstrated that long-term culture of SARS-CoV-2 in the presence of p38 inhibitor SB203580 does not easily select resistant viral mutants. In conclusion, we provide mechanistic insights on the regulation of SARS-CoV-2 replication by p38 MAPK.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SARS-CoV-2 hijacks p38β/MAPK11 to promote viral protein translation
C. A. Higgins, B. E. Nilsson-Payant, … J. R. Johnson·bioRxiv·Aug 20, 2021
- Inhibitors of VPS34 and lipid metabolism suppress SARS-CoV-2 replication
J. A. Silvas, A. S. Jureka, … C. F. Basler·bioRxiv·Jul 18, 2020
- Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
Markus Hoffmann, Heike Hofmann-Winkler, … Stefan Pöhlmann·EBioMedicinePeer-reviewed·Mar 1, 2021
- Pyronaridine Protects Against SARS-CoV-2 in Mouse
A. C. Puhl, G. F. Gomes, … S. Ekins·bioRxiv·Sep 30, 2021
- Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response
Andréa Cottignies-Calamarte, Flora Marteau, … Morgane Bomsel·Journal of VirologyPeer-reviewed·Jun 12, 2025
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
C. Ma, M. D. Sacco, … J. Wang·Cell ResearchPeer-reviewed·Jun 15, 2020